1owj: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The preparation and assessment of biological activity of 6-substituted | The preparation and assessment of biological activity of 6-substituted 2-naphthamidine inhibitors of the serine protease urokinase plasminogen activator (uPA, or urokinase) is described. 2-Naphthamidine was chosen as a starting point based on synthetic considerations and on modeling of substituent vectors. Phenyl amides at the 6-position were found to improve binding; replacement of the amide with other two-atom linkers proved ineffective. The phenyl group itself is situated near the S1' subsite; substitutions off of the phenyl group accessed S1' and other distant binding regions. Three new points of interaction were defined and explored through ring substitution. A solvent-exposed salt bridge with the Asp60A carboxylate was formed using a 4-alkylamino group, improving affinity to K(i) = 40 nM. Inhibitors also accessed two hydrophobic regions. One interaction is characterized by a tight hydrophobic fit made with a small dimple largely defined by His57 and His99; a weaker, less specific interaction involves alkyl groups reaching into the broad prime-side protein binding region near Val41 and the Cys42-Cys58 disulfide, displacing water molecules and leading to small gains in activity. Many inhibitors accessed two of these three regions. Affinities range as low as K(i) = 6 nM, and many compounds had K(i) < 100 nM, while moderate to excellent selectivity was gained versus four of five members of a panel of relevant serine proteases. Also, some selectivity against trypsin was generated via the interaction with Asp60A. X-ray structures of many of these compounds were used to inform our inhibitor design and to increase our understanding of key interactions. In combination with our exploration of 8-substitution patterns, we have identified a number of novel binding interactions for uPA inhibitors. | ||
==Disease== | ==Disease== | ||
Line 18: | Line 18: | ||
[[Category: U-plasminogen activator]] | [[Category: U-plasminogen activator]] | ||
[[Category: Geyer, A.]] | [[Category: Geyer, A.]] | ||
[[Category: Giranda, V | [[Category: Giranda, V L.]] | ||
[[Category: Klinghofer, V.]] | [[Category: Klinghofer, V.]] | ||
[[Category: Mantei, R.]] | [[Category: Mantei, R.]] | ||
[[Category: McClellan, W.]] | [[Category: McClellan, W.]] | ||
[[Category: Nienaber, V | [[Category: Nienaber, V L.]] | ||
[[Category: Rockway, T | [[Category: Rockway, T W.]] | ||
[[Category: Stewart, K.]] | [[Category: Stewart, K.]] | ||
[[Category: Weitzberg, M.]] | [[Category: Weitzberg, M.]] | ||
[[Category: Wendt, M | [[Category: Wendt, M D.]] | ||
[[Category: Zhao, X.]] | [[Category: Zhao, X.]] | ||
[[Category: 155]] | [[Category: 155]] | ||
Line 36: | Line 36: | ||
[[Category: serine protease]] | [[Category: serine protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:22:26 2008'' |